White Papers

The global biologics market is growing. Valued at $461.74 billion in 2022, the market value is forecast to increase at a compound annual growth rate of 10.3% from 2023 to 20301. This is due to the promise biologics have...

The roots of the Asahi Kasei Corporation stretch back to 1931 when it was founded in Tokyo, Japan, as a supplier of industrial chemicals, most notably ammonia and nitric acid. Over the years, the company has expanded its reach...

How the development of RTPs has helped optimize product transfer in pharmaceutical manufacturing In the fall of 1945, as World War II was concluding, three recent graduates of the Massachusetts Institute of Technology – Frank G. Chesley, Demetrius Jelatis...

Building on the Capsugel® legacy of developing and launching new and innovative oral solid dosage forms, Lonza has developed a unique manufacturing process to build a bi-layer capsule to assist in enteric delivery. Discover Capsugel® Enprotect® capsule. Available as...

Overcome your controlled release drug delivery challenges through extrusion-spheronization Combining best-in-class drug technology with a proven drug strategy Extrusion-spheronization (E-S) is a robust technique that synchronizes and controls API delivery, and is used to help manufacture today’s most complex and challenging...

Did you know more than 50% of patients prefer capsules over other dosage forms?1 Whether you are in the research or commercial phase of your drug development pipeline, our innovative Capsugel® capsules open the door to your next breakthrough drug. Our...

In a competitive manufacturing landscape, businesses can no longer afford to postpone digitization. Those who go digital improve agility, data integrity, and time to market. Those who stick to paper-based processes risk losing opportunities to their more flexible peers....